I did find this report (google cache link), which looks like good research on branded products, nearly all of it way over my head, but the summery;
"US prescription brands saw sales weighted real list price inflation of 6.5% in 1Q17 down from 10.9% in the year prior quarter, and real net price deflation of 1.2% as compared to 4.1% inflation in the year prior quarter"
I dont understand how pricing works over there, seems very complex, but an important thing for we investors to understand before we can make informed judgements, i need to do some research...
I did find this report (google cache link), which looks like...
-
- There are more pages in this discussion • 262 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MYX (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$4.56 |
Change
0.000(0.00%) |
Mkt cap ! $387.9M | |||
| Open | High | Low | Value | Volume |
| $4.55 | $4.64 | $4.53 | $551.8K | 120.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 2458 | $4.54 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $4.57 | 4730 | 4 |
View Market Depth
| Last trade - 16.10pm 26/06/2024 (20 minute delay) ? |
| MYX (ASX) Chart |